Dianthus Therapeutics | MGTA - Ricavi Di Vendita

Prezzo Delle Azioni
93.32
Cambio Giornaliero
-2.44 -2.55%
Mensile
19.64%
Annuale
391.68%
Q2 Previsione
87.32




I Saldi Cambiamento Data
Akebia Therapeutics USD 57.62M 1.14M 2025-12
Alaunos Therapeutics USD 2K 2K 2025-03
Avita Medical AUD 17.61M 805K 2025-12
Celltrion KRW 1.33T 0 2026-03
Cspc Pharmaceutical CNY 6.11B 502.75M 2025-12
Deva Holding AS TRY 2.32B 418.58M 2023-09
Dianthus Therapeutics USD 284K 112K 2025-12
Divis Laboratories Ltd INR 26.04B 1.11B 2025-12
IQVIA Holdings USD 4.36B 260M 2025-12
Kangmei Pharma CNY 1.37B 101.16M 2025-09
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Laboratorios Farma EUR 448.66M 67.82M 2023-12
Medical Developments International AUD 21.57M 12.04M 2025-12
Moderna USD 678M 342M 2025-12
Neuren Pharmaceuticals AUD 42.24M 28.1M 2025-12
Organigram Holdings CAD 63.54M 16.52M 2025-12
Organon & Co USD 1.51B 90M 2025-12
Pharma Mar EUR 90.2M 54.5M 2025-12
Qiagen NV USD 457.38M 6.06M 2025-12
Revvity USD 772.06M 73.06M 2025-12
Sartorius EUR 927.6M 84.4M 2025-12
Sino Biopharmaceutical CNY 14.26B 3.31B 2025-12
Tectonic Therapeutic USD 0 0 2024-12
Tilray USD 217.51M 74.75M 2025-12
Viatris USD 3.7B 60M 2025-12
Xeris Pharmaceuticals USD 85.81M 11.43M 2025-12
Zealand Pharma A/S 68.91M 19.35M 2025-12
Zhangzhou Pientzehuang Pharmaceutical CNY 2.88B 642.99M 2025-09